B46.2 Gastrointestinal mucormycosis

Name of the Condition

• Gastrointestinal mucormycosis
• ICD-10 Code: B46.2

Summary

Gastrointestinal mucormycosis is a rare and aggressive fungal infection affecting the gastrointestinal tract, caused by organisms in the order Mucorales. It primarily occurs in individuals with weakened immune systems or underlying health conditions, such as uncontrolled diabetes. The infection can involve the stomach, intestines, or other parts of the digestive system and may progress rapidly if not treated promptly.

Causes

Gastrointestinal mucormycosis is caused by fungi in the order Mucorales, which are commonly found in soil, decaying organic matter, and sometimes in hospital environments. Infection occurs when spores are ingested or enter the gastrointestinal tract, leading to tissue invasion. These fungi thrive in environments with high glucose levels, making them particularly dangerous for individuals with uncontrolled diabetes.

Risk Factors

• Uncontrolled diabetes mellitus, especially with diabetic ketoacidosis
• Weakened immune system (e.g., from chemotherapy, organ transplant, or HIV/AIDS)
• Prolonged corticosteroid use
• Malnutrition or iron overload
• Gastrointestinal surgery or trauma
• Prolonged use of broad-spectrum antibiotics

Symptoms

• Abdominal pain or cramping
• Nausea or vomiting
• Diarrhea, which may be bloody
• Fever
• Loss of appetite or weight loss
• Abdominal distension or tenderness
• Gastrointestinal bleeding (rare)

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging studies (e.g., CT scans or endoscopy), and laboratory tests. Endoscopic examination may reveal characteristic lesions, and tissue samples are analyzed via histopathology or fungal cultures to confirm the presence of Mucorales. Blood tests may assess immune function and rule out other infections.

Treatment Options

Treatment typically includes antifungal medications (e.g., amphotericin B) and surgical intervention to remove infected tissue. Managing underlying conditions, such as controlling blood sugar in diabetes, is critical. Supportive care, including hydration and nutritional support, may also be necessary.

Prognosis and Follow-Up

Prognosis depends on early diagnosis, the extent of infection, and the patient’s overall health. Prompt treatment improves outcomes, but the infection can be fatal if not addressed quickly. Follow-up care involves monitoring for recurrence and managing underlying risk factors.

Complications

• Perforation of the gastrointestinal tract
• Sepsis or systemic infection
• Spread of infection to other organs
• Long-term digestive issues or organ damage

Lifestyle & Prevention

• Maintain good hygiene and avoid contact with soil or decaying organic matter if immunocompromised.
• Control underlying conditions, such as diabetes, to reduce risk.
• Seek prompt medical care for persistent gastrointestinal symptoms.

When to Seek Professional Help

Consult a healthcare provider if you experience severe abdominal pain, persistent vomiting, bloody diarrhea, or fever, especially if you have a weakened immune system or uncontrolled diabetes.

Tips for Medical Coders

When coding B46.2 (Gastrointestinal mucormycosis), ensure documentation specifies the site of infection (e.g., stomach, intestines) and confirms the fungal cause. Note any underlying conditions, such as diabetes, as they may impact coding and reimbursement. Verify that the diagnosis aligns with clinical findings and laboratory results.